We are live on ! Find out more
MG

Marex Group Portfolio holdings

AUM $15.8B
1-Year Est. Return 31.44%
This Fund
S&P 500
This Quarter Est. Return
-10.64%
1 Year Est. Return
+31.44%
3 Year Est. Return
+143.62%
5 Year Est. Return
10 Year Est. Return
AUM
$15.9B
AUM Growth
+$1.74B
Cap. Flow
+$3.32B
Cap. Flow %
20.89%
Top 10 Hldgs %
25.45%
Holding
1,202
New
361
Increased
299
Reduced
251
Closed
239

Top Buys

Rank Stock Value
1
BMNR
BitMine Immersion Technologies
BMNR
+$345M
2
AVGO icon
Broadcom
AVGO
+$265M
3
IREN icon
Iris Energy
IREN
+$230M
4
TSLA icon
Tesla
TSLA
+$215M
5
ORCL icon
Oracle
ORCL
+$210M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$324M
2
BKNG icon
Booking.com
BKNG
+$162M
3
MA icon
Mastercard
MA
+$89.6M
4
NOW icon
ServiceNow
NOW
+$60.5M
5
NFLX icon
Netflix
NFLX
+$59.9M

Sector Composition

Rank Sector Weight
1 Technology 18.87%
2 Financials 9.37%
3 Consumer Discretionary 6.21%
4 Communication Services 5.85%
5 Healthcare 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBD icon
1151
CALL
Warner Bros
WBD
$65.1B
-20,000
Closed -$391K
WBD icon
1152
Warner Bros
WBD
$65.1B
-14,316
Closed -$280K
WHF icon
1153
WhiteHorse Finance
WHF
$140M
-21,500
Closed -$149K
WM icon
1154
Waste Management
WM
$95.3B
-5,808
Closed -$1.28M
WPM icon
1155
Wheaton Precious Metals
WPM
$50B
-2,956
Closed -$331K
WRBY icon
1156
CALL
Warby Parker
WRBY
$2.98B
-20,000
Closed -$552K
WRN
1157
Western Copper and Gold
WRN
$485M
-114,200
Closed -$225K
WTM icon
1158
White Mountains Insurance
WTM
$5.39B
-163
Closed -$272K
WWR icon
1159
Westwater Resources
WWR
$53.1M
-260,598
Closed -$247K
XBI icon
1160
State Street SPDR S&P Biotech ETF
XBI
$10.2B
-3,294
Closed -$378K
XLK icon
1161
State Street Technology Select Sector SPDR ETF
XLK
$116B
-3,856
Closed -$543K
XPOF icon
1162
Xponential Fitness
XPOF
$253M
-36,200
Closed -$283K
ZBH icon
1163
Zimmer Biomet
ZBH
$17.3B
-5,000
Closed -$493K
XTKG
1164
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
-166
Closed -$49.7K
MGX icon
1165
Metagenomi Therapeutics
MGX
$45.9M
-15,000
Closed -$34.5K
LGCL icon
1166
Lucas GC Ltd
LGCL
$75.3M
-468
Closed -$2.91K
AMDL icon
1167
GraniteShares 2x Long AMD Daily ETF
AMDL
$1.2B
-20,000
Closed -$205K
INTJ
1168
Intelligent Group
INTJ
$4.84M
-1,670
Closed -$16.7K
BTX
1169
BlackRock Technology and Private Equity Term Trust
BTX
$973M
-15,000
Closed -$101K
CNR
1170
Core Natural Resources Inc
CNR
$4.36B
-2,508
Closed -$209K
ETH
1171
Grayscale Ethereum Staking Mini ETF Shares
ETH
$1.71B
-9,300
Closed -$367K
FGL
1172
Founder Group Ltd
FGL
$1.12M
-319
Closed -$14.7K
KBDC
1173
Kayne Anderson BDC
KBDC
$886M
-56,098
Closed -$747K
GRAL
1174
GRAIL Inc
GRAL
$3.02B
-15,000
Closed -$887K
FETH
1175
Fidelity Ethereum Fund
FETH
$1.01B
-85,075
Closed -$3.53M

Similar funds

Marex Group's Q4 2025 Portfolio in Review

As of Q4 2025, Marex Group held 1,202 positions worth $15.9B, up 12% from $14.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Marex Group deployed $3.32B of net new capital in Q4 2025, opening 361 new positions and adding to 299 existing holdings. Its largest new stake was AdvisorShares Pure US Cannabis ETF: 6,900,000 shares worth $32.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Eli Lilly, an estimated $324M trimmed.

  • Marex Group's largest Q4 2025 buy was AdvisorShares Pure US Cannabis ETF: 6,900,000 shares worth $32.6M.
  • Marex Group added most to BitMine Immersion Technologies in Q4 2025, an estimated $345M increase.
  • Marex Group's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $324M.
  • Marex Group fully exited S&P Global in Q4 2025, selling an estimated $48.8M.
  • Marex Group's ten largest holdings make up 25% of its $15.9B portfolio in Q4 2025.
  • Marex Group opened 361 new positions and closed 239 in Q4 2025.
  • Marex Group's portfolio value rose 12% quarter-over-quarter to $15.9B.

Based on Marex Group's 13F filing for Q4 2025, filed 12 Feb 2026.